3 Stocks I'm Not Selling No Matter What the Market Does

The article argues for holding Medtronic, Realty Income, and Nucor through the next bear market, highlighting yields of 3.5%, 5.2%, and 0.9% respectively. It emphasizes dividend durability, with Medtronic at 49 consecutive years of dividend growth, Realty Income at 31 years, and Nucor as a Dividend King with 50+ annual hikes. The piece is largely a long-term stock-picking commentary rather than new company-specific news, so near-term market impact should be limited.

Analysis

The common thread here is not “defensive stocks” but duration: all three businesses monetize long-lived customer relationships and capital allocation discipline, which matters most when macro beta gets repriced. In a downturn, the market usually punishes anything that looks bond-like or cyclical, but the second-order opportunity is that cash-yielding names with visible dividend growth often get bid as substitutes for rate-sensitive fixed income when investors start discounting slower growth and easier policy. That makes the setup more interesting for MDT and O than for NUE, where the operating quality is excellent but the earnings stream is still much more exposed to industrial demand and pricing resets.

The bigger nuance is that these three names are not all “safe” in the same way. MDT is a re-rating story if execution keeps improving; the near-term catalyst is not recession resilience, but proof that margin normalization can coexist with mid-single-digit organic growth. O is less about operating upside and more about financing spread management: if long rates stabilize or drift lower, the market can re-expand its multiple even without dramatic FFO acceleration. NUE remains the highest-quality cyclical, but quality alone does not protect against a spread compression phase; it is the one most likely to underperform in the first leg of a downturn even if it outperforms on the other side.

Consensus may be underestimating how much of the perceived “defensiveness” is already reflected in price versus how much is contingent on rates. If the next bear market arrives with sticky inflation and a higher-for-longer rate backdrop, O is the one most vulnerable because its equity income appeal weakens relative to cash and Treasuries. Conversely, if the downturn is disinflationary and the Fed cuts aggressively, these names can work as crowded bond proxies, but the best risk/reward is still likely in buying MDT on weakness and treating NUE as a tactical wishlist name rather than a core defensive hold.

Key Decisions for Investors

• Long MDT on a 1-3 month pullback: build a starter position only if the stock sells off on broad market weakness, targeting a 12-18 month re-rating as execution improves; upside is multiple expansion plus dividend compounding, with risk limited by healthcare necessity demand.
• Maintain O as a core income hold, but hedge duration risk with a partial short in a REIT ETF or long-dated rates exposure if 10-year yields back up; the trade works best if rates fall, but the main risk is a higher-for-longer regime compressing the dividend spread.
• Do not chase NUE after strength; use it as a cyclical entry on recession-related drawdowns over the next 6-12 months, preferably after visible earnings revision cuts. The reward is asymmetry on recovery, but timing matters because the first bear-market phase can hit the stock hard.
• Pair trade: long MDT / short a more rate-sensitive defensive proxy basket if the market starts pricing a soft landing rather than a hard recession; MDT offers better idiosyncratic improvement, while O is more exposed to rate compression.
• If rates stay elevated, reduce O exposure before adding new capital and rotate incremental cash into shorter-duration dividend growers; if rates break lower sharply, add to O selectively as an income-supported multiple re-rating candidate.